_id
6915f207bc934aba376b2103
Ticker
RVMD
Name
Revolution Medicines Inc
Exchange
NASDAQ
Address
700 Saginaw Drive, Redwood City, CA, United States, 94063
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.revmed.com
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Last Close
78.51
Volume
1491165
Current Price
78.92
Change
0.5222264679658598
Last Updated
2025-12-03T13:11:37.733Z
Image
data:image/webp;base64,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
Ipo Date
2020-02-13T00:00:00.000Z
Market Cap
14558914560
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9380142857142858
Sentiment Sources
7
Rating
4.6667
Target Price
81.15
Strong Buy
8
Buy
4
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
315269000
Operating Income
-315269000
Interest Expense
11428000
Pretax Income
-305206000
Net Income
-305206000
Eps
-1.6128752688512982
Dividends Per Share
-
Shares Outstanding
193319805
Income Tax Expense
-
EBITDA
-302376000
Operating Margin
-
Total Other Income Expense Net
10063000
Cash
217442000
Short Term Investments
1714066000
Receivables
-
Inventories
-
Total Current Assets
1977489000
Property Plant Equipment
167376000
Total Assets
2251920000
Payables
74849000
Short Term Debt
16326000
Long Term Debt
-
Total Liabilities
655016000
Equity
1596904000
Depreciation
4338000
Change In Working Capital
36898000
Cash From Operations
-207311000
Capital Expenditures
3349000
Cash From Investing
24849000
Cash From Financing
-1592000
Net Change In Cash
-184054000
PE
-
PB
9.35191503058418
ROE
-19.11235741159143
ROA
-13.553145760062524
FCF
-210660000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
315269000
Quarters > 0 > income Statement > operating Income
-315269000
Quarters > 0 > income Statement > interest Expense
11428000
Quarters > 0 > income Statement > pretax Income
-305206000
Quarters > 0 > income Statement > net Income
-305206000
Quarters > 0 > income Statement > eps
-1.6128752688512982
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
189231000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-302376000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
10063000
Quarters > 0 > balance Sheet > cash
217442000
Quarters > 0 > balance Sheet > short Term Investments
1714066000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1977489000
Quarters > 0 > balance Sheet > property Plant Equipment
167376000
Quarters > 0 > balance Sheet > total Assets
2251920000
Quarters > 0 > balance Sheet > payables
74849000
Quarters > 0 > balance Sheet > short Term Debt
16326000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
655016000
Quarters > 0 > balance Sheet > equity
1596904000
Quarters > 0 > cash Flow > net Income
-305206000
Quarters > 0 > cash Flow > depreciation
4338000
Quarters > 0 > cash Flow > change In Working Capital
36898000
Quarters > 0 > cash Flow > cash From Operations
-207311000
Quarters > 0 > cash Flow > capital Expenditures
3349000
Quarters > 0 > cash Flow > cash From Investing
24849000
Quarters > 0 > cash Flow > cash From Financing
-1592000
Quarters > 0 > cash Flow > net Change In Cash
-184054000
Quarters > 0 > ratios > PE
-1.6128752688512982
Quarters > 0 > ratios > PB
9.35191503058418
Quarters > 0 > ratios > ROE
-19.11235741159143
Quarters > 0 > ratios > ROA
-13.553145760062524
Quarters > 0 > ratios > FCF
-210660000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
3802000
Quarters > 1 > income Statement > gross Profit
-3802000
Quarters > 1 > income Statement > operating Expenses
264714000
Quarters > 1 > income Statement > operating Income
-264714000
Quarters > 1 > income Statement > interest Expense
899000
Quarters > 1 > income Statement > pretax Income
-247787000
Quarters > 1 > income Statement > net Income
-247787000
Quarters > 1 > income Statement > eps
-1.3169938581283174
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
188145904
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-260912000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
16927000
Quarters > 1 > balance Sheet > cash
402438000
Quarters > 1 > balance Sheet > short Term Investments
1734733000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2176439000
Quarters > 1 > balance Sheet > property Plant Equipment
147049000
Quarters > 1 > balance Sheet > total Assets
2429568000
Quarters > 1 > balance Sheet > payables
56761000
Quarters > 1 > balance Sheet > short Term Debt
13088000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
564199000
Quarters > 1 > balance Sheet > equity
1865369000
Quarters > 1 > cash Flow > net Income
-247787000
Quarters > 1 > cash Flow > depreciation
-20742000
Quarters > 1 > cash Flow > change In Working Capital
-4303000
Quarters > 1 > cash Flow > cash From Operations
-221757000
Quarters > 1 > cash Flow > capital Expenditures
7450000
Quarters > 1 > cash Flow > cash From Investing
34276000
Quarters > 1 > cash Flow > cash From Financing
256583000
Quarters > 1 > cash Flow > net Change In Cash
69102000
Quarters > 1 > ratios > PE
-1.3169938581283174
Quarters > 1 > ratios > PB
7.9600737139300595
Quarters > 1 > ratios > ROE
-13.283538002400597
Quarters > 1 > ratios > ROA
-10.198809006374795
Quarters > 1 > ratios > FCF
-229207000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
205749000
Quarters > 2 > income Statement > gross Profit
-205749000
Quarters > 2 > income Statement > operating Expenses
35011000
Quarters > 2 > income Statement > operating Income
-240760000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-213416000
Quarters > 2 > income Statement > net Income
-213416000
Quarters > 2 > income Statement > eps
-1.1343105885854603
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
188146000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-237044000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
27344000
Quarters > 2 > balance Sheet > cash
333554000
Quarters > 2 > balance Sheet > short Term Investments
1769121000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2134582000
Quarters > 2 > balance Sheet > property Plant Equipment
142930000
Quarters > 2 > balance Sheet > total Assets
2365353000
Quarters > 2 > balance Sheet > payables
47507000
Quarters > 2 > balance Sheet > short Term Debt
12979000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
287203000
Quarters > 2 > balance Sheet > equity
2078150000
Quarters > 2 > cash Flow > net Income
-213416000
Quarters > 2 > cash Flow > depreciation
3716000
Quarters > 2 > cash Flow > change In Working Capital
2437000
Quarters > 2 > cash Flow > cash From Operations
-194435000
Quarters > 2 > cash Flow > capital Expenditures
3266000
Quarters > 2 > cash Flow > cash From Investing
-15949000
Quarters > 2 > cash Flow > cash From Financing
874000
Quarters > 2 > cash Flow > net Change In Cash
-209510000
Quarters > 2 > ratios > PE
-1.1343105885854603
Quarters > 2 > ratios > PB
7.145048394004283
Quarters > 2 > ratios > ROE
-10.26951856218271
Quarters > 2 > ratios > ROA
-9.022585635209628
Quarters > 2 > ratios > FCF
-197701000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
261592000
Quarters > 3 > income Statement > cost Of Revenue
188096000
Quarters > 3 > income Statement > gross Profit
-188096000
Quarters > 3 > income Statement > operating Expenses
28214000
Quarters > 3 > income Statement > operating Income
-216310000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-195322000
Quarters > 3 > income Statement > net Income
-194569000
Quarters > 3 > income Statement > eps
-1.1599600595386825
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
167737672
Quarters > 3 > income Statement > income Tax Expense
-753000
Quarters > 3 > income Statement > EBITDA
-212923000
Quarters > 3 > income Statement > operating Margin
-82.68983760971284
Quarters > 3 > income Statement > total Other Income Expense Net
20988000
Quarters > 3 > balance Sheet > cash
543064000
Quarters > 3 > balance Sheet > short Term Investments
1746235000
Quarters > 3 > balance Sheet > receivables
0
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2327632000
Quarters > 3 > balance Sheet > property Plant Equipment
141823000
Quarters > 3 > balance Sheet > total Assets
2558301000
Quarters > 3 > balance Sheet > payables
54427000
Quarters > 3 > balance Sheet > short Term Debt
12872000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
293097000
Quarters > 3 > balance Sheet > equity
2265204000
Quarters > 3 > cash Flow > net Income
-194569000
Quarters > 3 > cash Flow > depreciation
3387000
Quarters > 3 > cash Flow > change In Working Capital
42782000
Quarters > 3 > cash Flow > cash From Operations
-138290000
Quarters > 3 > cash Flow > capital Expenditures
1222000
Quarters > 3 > cash Flow > cash From Investing
-392903000
Quarters > 3 > cash Flow > cash From Financing
873805000
Quarters > 3 > cash Flow > net Change In Cash
341802000
Quarters > 3 > ratios > PE
-1.1599600595386825
Quarters > 3 > ratios > PB
5.8440021623836085
Quarters > 3 > ratios > ROE
-8.589469204539634
Quarters > 3 > ratios > ROA
-7.60539905194893
Quarters > 3 > ratios > FCF
-139512000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.5333190617450075
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
592225000
Annuals > 0 > income Statement > gross Profit
-592225000
Annuals > 0 > income Statement > operating Expenses
97299000
Annuals > 0 > income Statement > operating Income
-689524000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-600846000
Annuals > 0 > income Statement > net Income
-600093000
Annuals > 0 > income Statement > eps
-3.5775684307816076
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
167737672
Annuals > 0 > income Statement > income Tax Expense
-753000
Annuals > 0 > income Statement > EBITDA
-589022000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
88678000
Annuals > 0 > balance Sheet > cash
543064000
Annuals > 0 > balance Sheet > short Term Investments
1746235000
Annuals > 0 > balance Sheet > receivables
0
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2327632000
Annuals > 0 > balance Sheet > property Plant Equipment
141823000
Annuals > 0 > balance Sheet > total Assets
2558301000
Annuals > 0 > balance Sheet > payables
54427000
Annuals > 0 > balance Sheet > short Term Debt
12872000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
293097000
Annuals > 0 > balance Sheet > equity
2265204000
Annuals > 0 > cash Flow > net Income
-600093000
Annuals > 0 > cash Flow > depreciation
11824000
Annuals > 0 > cash Flow > change In Working Capital
1168000
Annuals > 0 > cash Flow > cash From Operations
-557436000
Annuals > 0 > cash Flow > capital Expenditures
10308000
Annuals > 0 > cash Flow > cash From Investing
-554394000
Annuals > 0 > cash Flow > cash From Financing
959413000
Annuals > 0 > cash Flow > net Change In Cash
-153084000
Annuals > 0 > ratios > PE
-3.5775684307816076
Annuals > 0 > ratios > PB
5.5766827527763505
Annuals > 0 > ratios > ROE
-26.49178617025222
Annuals > 0 > ratios > ROA
-23.456700364812427
Annuals > 0 > ratios > FCF
-567744000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
11580000
Annuals > 1 > income Statement > cost Of Revenue
411244000
Annuals > 1 > income Statement > gross Profit
-399664000
Annuals > 1 > income Statement > operating Expenses
87521000
Annuals > 1 > income Statement > operating Income
-487185000
Annuals > 1 > income Statement > interest Expense
303000
Annuals > 1 > income Statement > pretax Income
-439891000
Annuals > 1 > income Statement > net Income
-436367000
Annuals > 1 > income Statement > eps
-3.856540037178479
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
113149869
Annuals > 1 > income Statement > income Tax Expense
-3524000
Annuals > 1 > income Statement > EBITDA
-456675000
Annuals > 1 > income Statement > operating Margin
-4207.124352331606
Annuals > 1 > income Statement > total Other Income Expense Net
47294000
Annuals > 1 > balance Sheet > cash
696148000
Annuals > 1 > balance Sheet > short Term Investments
1156807000
Annuals > 1 > balance Sheet > receivables
1254000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
1879281000
Annuals > 1 > balance Sheet > property Plant Equipment
100014000
Annuals > 1 > balance Sheet > total Assets
2061705000
Annuals > 1 > balance Sheet > payables
61788000
Annuals > 1 > balance Sheet > short Term Debt
7369000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
235511000
Annuals > 1 > balance Sheet > equity
1826194000
Annuals > 1 > cash Flow > net Income
-436367000
Annuals > 1 > cash Flow > depreciation
9309000
Annuals > 1 > cash Flow > change In Working Capital
40662000
Annuals > 1 > cash Flow > cash From Operations
-350572000
Annuals > 1 > cash Flow > capital Expenditures
7729000
Annuals > 1 > cash Flow > cash From Investing
-342598000
Annuals > 1 > cash Flow > cash From Financing
1229200000
Annuals > 1 > cash Flow > net Change In Cash
534736000
Annuals > 1 > ratios > PE
-3.856540037178479
Annuals > 1 > ratios > PB
4.666161773825783
Annuals > 1 > ratios > ROE
-23.89488739969576
Annuals > 1 > ratios > ROA
-21.165346157670474
Annuals > 1 > ratios > FCF
-358301000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-30.941364421416235
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
35380000
Annuals > 2 > income Statement > cost Of Revenue
253073000
Annuals > 2 > income Statement > gross Profit
-217693000
Annuals > 2 > income Statement > operating Expenses
40586000
Annuals > 2 > income Statement > operating Income
-258279000
Annuals > 2 > income Statement > interest Expense
9656000
Annuals > 2 > income Statement > pretax Income
-249125000
Annuals > 2 > income Statement > net Income
-248705000
Annuals > 2 > income Statement > eps
-3.0846548328853314
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
80626525
Annuals > 2 > income Statement > income Tax Expense
-420000
Annuals > 2 > income Statement > EBITDA
-248623000
Annuals > 2 > income Statement > operating Margin
-730.0141322781232
Annuals > 2 > income Statement > total Other Income Expense Net
9154000
Annuals > 2 > balance Sheet > cash
161412000
Annuals > 2 > balance Sheet > short Term Investments
483531000
Annuals > 2 > balance Sheet > receivables
4673000
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
660185000
Annuals > 2 > balance Sheet > property Plant Equipment
73736000
Annuals > 2 > balance Sheet > total Assets
811930000
Annuals > 2 > balance Sheet > payables
21306000
Annuals > 2 > balance Sheet > short Term Debt
6773000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
126742000
Annuals > 2 > balance Sheet > equity
685188000
Annuals > 2 > cash Flow > net Income
-248705000
Annuals > 2 > cash Flow > depreciation
9656000
Annuals > 2 > cash Flow > change In Working Capital
-13489000
Annuals > 2 > cash Flow > cash From Operations
-224401000
Annuals > 2 > cash Flow > capital Expenditures
10816000
Annuals > 2 > cash Flow > cash From Investing
-24116000
Annuals > 2 > cash Flow > cash From Financing
301432000
Annuals > 2 > cash Flow > net Change In Cash
52915000
Annuals > 2 > ratios > PE
-3.0846548328853314
Annuals > 2 > ratios > PB
8.861777494278943
Annuals > 2 > ratios > ROE
-36.29733737310052
Annuals > 2 > ratios > ROA
-30.63133521362679
Annuals > 2 > ratios > FCF
-235217000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-6.648304126625212
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
29390000
Annuals > 3 > income Statement > cost Of Revenue
186948000
Annuals > 3 > income Statement > gross Profit
-157558000
Annuals > 3 > income Statement > operating Expenses
30450000
Annuals > 3 > income Statement > operating Income
-188008000
Annuals > 3 > income Statement > interest Expense
12000
Annuals > 3 > income Statement > pretax Income
-187091000
Annuals > 3 > income Statement > net Income
-187091000
Annuals > 3 > income Statement > eps
-2.5697167402738446
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
72806079
Annuals > 3 > income Statement > income Tax Expense
-7320000
Annuals > 3 > income Statement > EBITDA
-179747000
Annuals > 3 > income Statement > operating Margin
-639.7005784280368
Annuals > 3 > income Statement > total Other Income Expense Net
917000
Annuals > 3 > balance Sheet > cash
108497000
Annuals > 3 > balance Sheet > short Term Investments
468557000
Annuals > 3 > balance Sheet > receivables
5929000
Annuals > 3 > balance Sheet > inventories
-12719000
Annuals > 3 > balance Sheet > total Current Assets
589773000
Annuals > 3 > balance Sheet > property Plant Equipment
71236000
Annuals > 3 > balance Sheet > total Assets
737988000
Annuals > 3 > balance Sheet > payables
14057000
Annuals > 3 > balance Sheet > short Term Debt
6214000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
135420000
Annuals > 3 > balance Sheet > equity
602568000
Annuals > 3 > cash Flow > net Income
-187091000
Annuals > 3 > cash Flow > depreciation
7332000
Annuals > 3 > cash Flow > change In Working Capital
8724000
Annuals > 3 > cash Flow > cash From Operations
-147180000
Annuals > 3 > cash Flow > capital Expenditures
6528000
Annuals > 3 > cash Flow > cash From Investing
-142117000
Annuals > 3 > cash Flow > cash From Financing
294179000
Annuals > 3 > cash Flow > net Change In Cash
4882000
Annuals > 3 > ratios > PE
-2.5697167402738446
Annuals > 3 > ratios > PB
9.099430785388538
Annuals > 3 > ratios > ROE
-31.048943853639756
Annuals > 3 > ratios > ROA
-25.35149623029101
Annuals > 3 > ratios > FCF
-153708000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-5.229942157196326
Annuals > 3 > health Score
26
Valuation > metrics > PE
-1.6128752688512982
Valuation > metrics > PB
9.35191503058418
Valuation > final Score
20
Valuation > verdict
211.7% Overvalued
Profitability > metrics > ROE
-19.11235741159143
Profitability > metrics > ROA
-15.434017584927147
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4101786957763272
Risk > metrics > Interest Coverage
-27.58741687084354
Risk > final Score
-50
Risk > verdict
High
Liquidity > metrics > Current Ratio
21.68893885385248
Liquidity > metrics > Quick Ratio
21.68893885385248
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
21.559978376163915
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-1118
Prev Risks > 1
19
Prev Risks > 2
11
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:07:51.014Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-02
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-1.54
Earnings History > 0 > eps Difference
1.54
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-05
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.61
Earnings History > 1 > eps Estimate
-1.41
Earnings History > 1 > eps Difference
-0.2
Earnings History > 1 > surprise Percent
-14.1844
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.31
Earnings History > 2 > eps Estimate
-1.12
Earnings History > 2 > eps Difference
-0.19
Earnings History > 2 > surprise Percent
-16.9643
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-1.13
Earnings History > 3 > eps Estimate
-0.75
Earnings History > 3 > eps Difference
-0.38
Earnings History > 3 > surprise Percent
-50.6667
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-24
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.12
Earnings History > 4 > eps Estimate
-0.9645
Earnings History > 4 > eps Difference
-0.1555
Earnings History > 4 > surprise Percent
-16.1223
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-06
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.94
Earnings History > 5 > eps Estimate
-0.89
Earnings History > 5 > eps Difference
-0.05
Earnings History > 5 > surprise Percent
-5.618
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.81
Earnings History > 6 > eps Estimate
-0.77
Earnings History > 6 > eps Difference
-0.04
Earnings History > 6 > surprise Percent
-5.1948
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.7
Earnings History > 7 > eps Estimate
-0.75
Earnings History > 7 > eps Difference
0.05
Earnings History > 7 > surprise Percent
6.6667
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-26
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.14
Earnings History > 8 > eps Estimate
-0.88
Earnings History > 8 > eps Difference
-0.26
Earnings History > 8 > surprise Percent
-29.5455
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-06
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.99
Earnings History > 9 > eps Estimate
-1.01
Earnings History > 9 > eps Difference
0.02
Earnings History > 9 > surprise Percent
1.9802
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.92
Earnings History > 10 > eps Estimate
-0.82
Earnings History > 10 > eps Difference
-0.1
Earnings History > 10 > surprise Percent
-12.1951
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-08
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.72
Earnings History > 11 > eps Estimate
-0.81
Earnings History > 11 > eps Difference
0.09
Earnings History > 11 > surprise Percent
11.1111
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-27
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.63
Earnings History > 12 > eps Estimate
-0.82
Earnings History > 12 > eps Difference
0.19
Earnings History > 12 > surprise Percent
23.1707
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-07
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.87
Earnings History > 13 > eps Estimate
-0.84
Earnings History > 13 > eps Difference
-0.03
Earnings History > 13 > surprise Percent
-3.5714
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-09
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.82
Earnings History > 14 > eps Estimate
-0.85
Earnings History > 14 > eps Difference
0.03
Earnings History > 14 > surprise Percent
3.5294
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.78
Earnings History > 15 > eps Estimate
-0.77
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-1.2987
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.71
Earnings History > 16 > eps Estimate
-0.64
Earnings History > 16 > eps Difference
-0.07
Earnings History > 16 > surprise Percent
-10.9375
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.72
Earnings History > 17 > eps Estimate
-0.63
Earnings History > 17 > eps Difference
-0.09
Earnings History > 17 > surprise Percent
-14.2857
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-11
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.6
Earnings History > 18 > eps Estimate
-0.56
Earnings History > 18 > eps Difference
-0.04
Earnings History > 18 > surprise Percent
-7.1429
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-10
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.53
Earnings History > 19 > eps Estimate
-0.52
Earnings History > 19 > eps Difference
-0.01
Earnings History > 19 > surprise Percent
-1.9231
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-02
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.52
Earnings History > 20 > eps Estimate
-0.38
Earnings History > 20 > eps Difference
-0.14
Earnings History > 20 > surprise Percent
-36.8421
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-12
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.42
Earnings History > 21 > eps Estimate
-0.39
Earnings History > 21 > eps Difference
-0.03
Earnings History > 21 > surprise Percent
-7.6923
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-10
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.46
Earnings History > 22 > eps Estimate
-0.36
Earnings History > 22 > eps Difference
-0.1
Earnings History > 22 > surprise Percent
-27.7778
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-14
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.74
Earnings History > 23 > eps Estimate
-0.33
Earnings History > 23 > eps Difference
-0.41
Earnings History > 23 > surprise Percent
-124.2424
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-30
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-6.52
Earnings History > 24 > eps Estimate
-0.41
Earnings History > 24 > eps Difference
-6.11
Earnings History > 24 > surprise Percent
-1490.2439
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-27
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.37
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.37
Earnings History > 25 > surprise Percent
-
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHRT Financial LP Increases Position in Revolution Medicines, Inc. $RVMD MarketBeat
Read more →Holocene Advisors LP Lowers Holdings in Revolution Medicines, Inc. $RVMD MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$81.15
Analyst Picks
Strong Buy
8
Buy
4
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 96.43% of the total shares of Revolution Medicines Inc
1.
Vanguard Group Inc(8.4317%)
since
2025/06/30
2.
Farallon Capital Management, L.L.C.(7.6635%)
since
2025/06/30
3.
HHG PLC(5.6655%)
since
2025/06/30
4.
Wellington Management Company LLP(5.4885%)
since
2025/06/30
5.
Baker Bros Advisors LP(5.0098%)
since
2025/06/30
6.
BlackRock Inc(4.6334%)
since
2025/06/30
7.
FMR Inc(4.4536%)
since
2025/06/30
8.
Nextech Invest, Ltd.(4.0662%)
since
2025/06/30
9.
Paradigm Biocapital Advisors LP(3.2596%)
since
2025/06/30
10.
Vanguard Total Stock Mkt Idx Inv(2.8228%)
since
2025/07/31
11.
Bvf Inc(2.6653%)
since
2025/06/30
12.
State Street Corp(2.5244%)
since
2025/06/30
13.
T. Rowe Price Associates, Inc.(2.5153%)
since
2025/06/30
14.
T. Rowe Price Investment Management,Inc.(2.5085%)
since
2025/06/30
15.
Bellevue Group AG(2.4497%)
since
2025/06/30
16.
BB Biotech AG Ord(2.34%)
since
2024/12/31
17.
Alphabet Inc(2.2111%)
since
2025/06/30
18.
Vanguard Small Cap Index(2.1784%)
since
2025/07/31
19.
Vanguard Health Care Inv(2.0723%)
since
2025/06/30
20.
Holocene Advisors, LP(1.9434%)
since
2025/06/30
21.
Deerfield Management Co(1.8103%)
since
2025/06/30
22.
Fidelity Growth Compy Commingled Pl S(1.752%)
since
2025/07/31
23.
Geode Capital Management, LLC(1.6016%)
since
2025/06/30
24.
Woodline Partners LP(1.5597%)
since
2025/06/30
25.
Casdin Capital, LLC(1.5449%)
since
2025/06/30
26.
Janus Inst Mid Cap Growth CF(1.2861%)
since
2025/06/30
27.
Janus Henderson Enterprise D(1.2861%)
since
2025/06/30
28.
Fidelity Growth Company Fund(1.2818%)
since
2025/07/31
29.
Vanguard Small Cap Growth Index Inv(1.2285%)
since
2025/07/31
30.
Vanguard Institutional Extnd Mkt Idx Tr(1.0061%)
since
2025/07/31
31.
SPDR® S&P Biotech ETF(0.9988%)
since
2025/08/31
32.
US Small-Cap Growth II Equity Comp(0.8871%)
since
2025/06/30
33.
T. Rowe Price US Mid-Cap Growth Equity(0.8024%)
since
2025/06/30
34.
T. Rowe Price Mid-Cap Growth(0.801%)
since
2025/07/31
35.
T. Rowe Price Health Sciences(0.7277%)
since
2025/07/31
36.
Vanguard Explorer Inv(0.662%)
since
2025/06/30
37.
Janus Henderson Global Life Sciences D(0.6064%)
since
2025/06/30
38.
Janus Henderson Global Life Sciences(0.6064%)
since
2025/06/30
39.
Janus Henderson Glb Life Scn I2 USD(0.5625%)
since
2025/07/31
40.
iShares Biotechnology ETF(0.5167%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-1.54
Date
2025-09-30
EPS Actual
-1.61
EPS Estimate
-1.41
EPS Difference
-0.2
Surprise Percent
-14.1844%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.